The Afssaps (French Health Products Safety Agency) reports that a packaging error of the Atoderm PP anti-recurrence product - Bioderma brand emollient balm caused a burn in a 4-year-old child. The batch concerned, No 34481, is withdrawn from the market. You are advised not to use it and to bring it back to your point of sale if you have one at home.
15 June 2009 The text of the Afssaps communiqué: L’ was informed of the packaging defect of a cosmetic product of the brand Atoderm (Atoderm PP anti-recurrence - Emollient balm - batch n°34481) which caused an adverse skin effect (burn) in a 4-year-old child with eczema. The evolution of the adverse reaction was favourable, with no sequelae, after discontinuation of the product and implementation of symptomatic treatment. The Agency recommends not to use the product and to return it to the point of sale. The product concerned by the packaging defect is"Atoderm PP anti-recurrence - Emollient balm" (lot n°34481) marketed by Bioderma laboratories. Indeed, some bottles in this range contain a blue foaming product instead of the emollient balm (white) advertised on the bottle. Taking into account the case reported to the Afssaps, and in order to avoid similar effects when the foaming product is used without rinsing, the Agency recommends that people who hold a bottle of the product"Atoderm PP anti-recurrence - Emollient Balm" (lot n°34481) not to use it and to return it to their point of sale. The Bioderma laboratory has already made the necessary arrangements with wholesalers and sales outlets to withdraw products with this packaging defect from sale and to proceed with its withdrawal. The Bioderma laboratory has also set up a telephone number to answer consumers' questions: 04 72 11 48 00 . The Afssaps recalls that any adverse reaction following the use of cosmetic products must be reported to the Agency.
See the press release on the Afssaps website
